The best indicator for ResMed (RMD)
We backtested 382 indicators across daily, weekly and hourly charts on real ResMed (RMD) history. Here's what actually worked — risk-adjusted, out-of-sample, with costs.
Detrended Price Osc.
On the weekly chart, this is the strongest risk-adjusted edge we found for ResMed (RMD) over ~31.1 years — trailing buy-and-hold by 4.7% CAGR.
Best multi-indicator combo
Going long only when all 2 agree was the strongest confluence setup we found for ResMed (RMD) — trailing buy-and-hold by 10.1% CAGR, out-of-sample. Fewer, higher-conviction trades than any single indicator.
The winner on each chart
Every indicator, ranked
Ranked by Sharpe (risk-adjusted return). Hypothetical, fees included.
| # | Indicator | TF | CAGR | Sharpe | Max DD | Win | Trades | vs B&H |
|---|---|---|---|---|---|---|---|---|
| 1 | Detrended Price Osc. ✓ | Weekly | 16.0% | 0.72 | -40.3% | 56.1% | 180 | -4.7% |
| 2 | DeMarker ✓ | Daily | 14.3% | 0.69 | -34.6% | 71.8% | 110 | -6.5% |
| 3 | Markov Regime ✓ | Daily | 18.6% | 0.64 | -61.6% | 63.9% | 119 | -2.3% |
| 4 | MA Envelope ✓ | Daily | 13.3% | 0.62 | -63.6% | 67.7% | 217 | -7.5% |
| 5 | QQE ✓ | Weekly | 17.0% | 0.62 | -62.1% | 57.8% | 90 | -3.7% |
| 6 | SMA 20/50 Cross ✓ | Weekly | 17.1% | 0.66 | -54.5% | 78.6% | 14 | -3.6% |
| 7 | QQE ✓ | Daily | 17.3% | 0.61 | -59.3% | 45.8% | 454 | -3.5% |
| 8 | ROC (60) ✓ | Weekly | 15.8% | 0.61 | -54.5% | 67.7% | 31 | -4.9% |
| 9 | CCI (100) ✓ | Weekly | 15.6% | 0.61 | -55.2% | 47.6% | 21 | -5.2% |
| 10 | Lorentzian Classification ✓ | Weekly | 15.1% | 0.61 | -59.5% | 55.6% | 250 | -5.6% |
| 11 | Volume Flow Indicator ✓ | Daily | 15.4% | 0.6 | -57.3% | 47.8% | 67 | -5.4% |
| 12 | Murrey Math Lines ✓ | Daily | 12.2% | 0.6 | -52.8% | 83.1% | 77 | -8.6% |
| 13 | Williams %R ✓ | Daily | 12.0% | 0.59 | -66.3% | 66.0% | 194 | -8.9% |
| 14 | Williams %R ✓ | Weekly | 11.1% | 0.59 | -40.3% | 76.9% | 39 | -9.7% |
✓ = held up out-of-sample. Hypothetical, costs included. See methodology.
For ResMed (RMD), Detrended Price Osc. on the weekly timeframe gave the best balance of return and risk in our test. It still trailed buy-and-hold on raw return — but remember: this is a hypothetical backtest of a standard rule, not a recommendation. Markets change. See the methodology and disclaimer.
More stock
Get alerted when ResMed’s signal flips
We track ResMed daily. Its backtested best indicator, Detrended Price Osc. (Weekly), is flat right now — we'll email you the moment that changes. Free, no spam, unsubscribe any time.